Combination of Tarlatamab and Temozolomide in Patients With Central Nervous System Tumors

NCT07243470 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Glioma
CNS Tumor, Adult
CNS Tumor, Childhood

Interventions

DRUG: Tarlatamab
DRUG: Temozolomide (TMZ)

Sponsor

Centre Leon Berard

Collaborators

[object Object]
[object Object]